Smith & Nephew PLC (SNN)
23.84
-0.16
(-0.69%)
USD |
NYSE |
Apr 19, 16:00
23.84
0.00 (0.00%)
After-Hours: 20:00
Smith & Nephew Total Assets (Quarterly): 9.987B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.987B |
| June 30, 2023 | 9.844B |
| June 30, 2023 | 9.844B |
| December 31, 2022 | 9.966B |
| June 30, 2022 | 10.10B |
| June 30, 2022 | 10.10B |
| December 31, 2021 | 10.92B |
| June 30, 2021 | 10.93B |
| June 30, 2021 | 10.93B |
| December 31, 2020 | 11.01B |
| June 30, 2020 | 9.539B |
| June 30, 2020 | 9.539B |
| December 31, 2019 | 9.299B |
| June 30, 2019 | 8.946B |
| June 30, 2019 | 8.946B |
| December 31, 2018 | 8.059B |
| June 30, 2018 | 7.713B |
| June 30, 2018 | 7.713B |
| December 31, 2017 | 7.866B |
| June 30, 2017 | 7.439B |
| June 30, 2017 | 7.439B |
| December 31, 2016 | 7.344B |
| June 30, 2016 | 7.502B |
| June 30, 2016 | 7.502B |
| December 31, 2015 | 7.167B |
| Date | Value |
|---|---|
| June 30, 2015 | 7.215B |
| June 30, 2015 | 7.215B |
| December 31, 2014 | 7.306B |
| September 30, 2014 | 7.65B |
| June 30, 2014 | 7.742B |
| June 30, 2014 | 7.742B |
| March 31, 2014 | 5.94B |
| December 31, 2013 | 5.819B |
| September 30, 2013 | 5.567B |
| June 30, 2013 | 5.452B |
| March 31, 2013 | 5.465B |
| December 31, 2012 | 5.642B |
| September 30, 2012 | 4.997B |
| June 30, 2012 | 4.812B |
| March 31, 2012 | 4.884B |
| December 31, 2011 | 4.747B |
| September 30, 2011 | 4.821B |
| June 30, 2011 | 4.909B |
| March 31, 2011 | 4.79B |
| December 31, 2010 | 4.733B |
| September 30, 2010 | 4.878B |
| June 30, 2010 | 4.583B |
| March 31, 2010 | 4.535B |
| December 31, 2009 | 4.565B |
| September 30, 2009 | 4.627B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
8.946B
Minimum
Jun 2019
11.01B
Maximum
Dec 2020
9.995B
Average
9.966B
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| AstraZeneca PLC | 101.12B |
| Adaptimmune Therapeutics PLC | 282.62M |
| Biodexa Pharmaceuticals Plc | 10.04M |
| Verona Pharma PLC | 308.12M |
| NuCana PLC | 35.43M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.77B |
| Shareholders Equity (Quarterly) | 5.217B |
| Debt to Equity Ratio | 0.553 |
| Current Ratio | 1.774 |
| Net Debt Paydown Yield | -0.47% |